FDA approved first gene therapy for children with metachromatic leukodystrophy
On Mar. 18, 2024, the U.S. Food and Drug Administration (FDA) approved Orchard Therapeutics’ Lenmeldy (atidarsagene autotemcel), the…
On Mar. 18, 2024, the U.S. Food and Drug Administration (FDA) approved Orchard Therapeutics’ Lenmeldy (atidarsagene autotemcel), the…
On Mar. 14, 2024, Microsoft and the Fred Hutch announced a collaboration to end cancer faster, applying machine…
On Mar. 14, 2024, the U.S. Food and Drug Administration (FDA) approved Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the…
On Mar. 14, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM) awarded $56 million to fund various clinical…
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
On Feb. 14, 2024, the U.S. Food and Drug Administration (FDA) approved Eicos Sciences’ Aurlumyn (iloprost) injection to…
On Feb. 13, 2024, CRISPR Therapeutics announced that the European Commission had granted conditional marketing authorization to CASGEVY…
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
On Feb. 8, 2024, Deschutes County Health Services in Bend, Oregon confirmed a case of human plague in…
On Feb. 2, 2024, Chinese scientists announced they have assembled the world’s most detailed human genome yet, a…
On Jan. 25, 2024, a study led by the University of Edinburgh, is the largest genetic study of…
On Jan. 25, 2024, dozens of noted scientists, philanthropists, and Washington University, state and local leaders celebrated the…
On Jan. 24, 2024, Oregon Health & Science University announced that Pamela Runner, 77, of Corvallis, became the…
On Jan. 16, 2024, the U.S. Food and Drug Administration (FDA) announced it had approved CRISPR Therapeutics’ CASGEVY…
On Jan. 15, 2024, CSL announced that Swissmedic had authorised HEMGENIX® (etranacogene dezaparvovec), the first and currently only gene…
On Jan. 10, 2024, an National Institutes of Health (NIH) supported study announced an n atlas revealing the…
On Jan. 9, 2024, Biogen and Eisai announced that humanized anti- soluble aggregated amyloid-beta (Aβ) monoclonal antibody ‘LEQEMBI’…
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
On Dec. 14, 2023, the Department of Energy’s Pacific Northwest National Laboratory announced that it had created the…
On Dec. 14, 2023, the University of Alberta announced that a study published in Nature sheds light on…